Angiodynamics Initiates Thrombectomy Trial In Europe After Showing Positive Trial Results in US

According to Zacks Equity Research, the new trial seeks to support AlphaVac’s adoption in the European market, where pulmonary embolism prevalence and severity is an estimated 435,000 events annually.